Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
PwC: BupaCSH MSK contract could damage local trust

An independent report on BupaCSH’s musculoskeletal services (MSK) contract has stated that the new service could “negatively impact” the local NHS trust.

Coastal West Sussex Clinical Commissioning Group (CCG) awarded BupaCSH a five-year, £235 million contract to deliver local MSK services in September 2014. Previously, the services were managed by Western Sussex Hospitals Foundation Trust.

However, Coastal West Sussex CCF and the trust jointly commissioned PwC to carry out an independent assessment of the contract after the trust raised concerns about its impact on wider hospital services.

PwC’s report concluded that it could “achieve benefits” but that the “cumulative impact of loss of MSK services” could add up to £13.4 million over the five-year contract. This would result in the trust falling into deficit. This could happen “specifically if providers conduct outpatient activity but do not also provide inpatient services”.

This news comes after Bedford Hospital NHS Trust refused to sign the contract for local MSK services awarded to Circle in November 2014 due to potential impact on the viability of the trauma service.

Marianne Griffiths, chief executive of the Western Sussex Hospitals Foundation Trust, said that if the implications were not mitigated it would “seriously affect the care we are able to provide our patients in our hospitals”.

The new service is still due to begin in April, but if this is to be achieved “there is a considerable amount of work to be completed by all parties,” the auditors concluded.

The CCG’s chief clinical officer Katie Armstrong said the group will now “fully explore the financial and clinical implications” and stated that the contract will not be signed until it has been reassured.

BupaCSH is a joint venture between Bupa and Central Surrey Healthcare. Under the terms of the Sussex MSK contract, BupaCSH is the prime contractor and has to work with other providers to coordinate all treatment and care for people with muscle, joint and bone conditions in the area.

Related articles:

Posted on: 07/01/2015

Latest news stories

Private equity house Livingbridge is on the verge of acquiring a 30% stake in home care provider Helping Hands, HealthInvestor UK understands.
Around 1.3 million NHS employees are in line for a pay increase of 6.5% or more over three years, it has been confirmed.
Auckland-based ehealth software company Orion Health has been commissioned by the four health boards in the North of Scotland – NHS Highland, NHS Grampian, NHS Orkney and NHS Shetland – a to build a new web-based portal.
Jeremy Hunt has indicated that a cap on social care costs paid by individuals may be pending, after saying that dementia sufferers should not be hit by ‘punitive’ costs.
Group operating profit fell 6% at Mears Group to £39.2 million, compared with £41.9 million in 2016, the results for the year to 31 December 2017 show.


Christie + Co

my images

interview: Adrian Stevensen
One Healthcare CEO Adrian Stevensen tells Ploy Radford how the new provider is overcoming the barriers to entry in the UK private hospital market
Read more

private finance initiative

The collapse of Carillion may have scuppered PF2's chances of survival. Mark Hellowell investigates
Read more

HealthInvestor blog
Spire’s new boss has unveiled his plans to restore the hospital group’s ailing fortunes and share price

Click here to view the Editor's blog

... is a problem halved? Clare Connell and Ryan Perrott analyse whether the Shared Lives scheme is the most effective method for moving more care into the community
Pauline Issard recounts how she harnessed technology to combat frustrations with equine health issues
BGF has backed a one-of-a-kind business bridging the gap between hospitals with blocked beds and social care providers
A new IVF clinic from the team behind CREATE Fertility plans to make treatment more affordable, transparent and accessible, with a ‘shoebox’ technique at its core. Sarah Williams speaks to abc ivf chief executive Praful Nargund
The collapse of Carillion may have scuppered PF2’s chances of survival. Mark Hellowell investigates

Click here to search all feature articles